Carlene Moore, PhD, an assistant professor in neurology, is opening up new avenues of research in the quest to develop novel therapies for migraines and other painful neurological diseases.

Medical students Lily Guo and Linda Li each had different experiences before coming to Duke, but an affinity group for Asian American students gave them both a sense of belonging that they said the

Asiya Gusa, PhD, assistant professor of molecular genetics and microbiology, has been named a Canadian Institute for Advanced Research (CIFAR) Azrieli Global Schol

Autologous conditioned serum (ACS) -- a biologic therapy that famous athletes swear by to treat arthritis and sports injuries -- also shows benefit for the kind of neurological pain caused by chemotherapy or diabetes.

A Conversation with Svati Shah, MD, about One DukeGEN, an initiative that uses genetics and advanced technologies to quickly translate scientific discovery into better clinical treatments.

The COVID-19 pandemic forced medical residency programs to change their approach to interviewing, switching from traditional in-person meetings to virtual conversations via computer video. &nb

Susanna Naggie, MD, MHS, has been named director of the Duke Clinical and Translational Science Institute (CTSI), effective immediately. 

A new study from researchers in the Duke University School of Medicine suggests a potential targeted therapy for otherwise untreatable forms of advanced prostate cancer.

Medical students at Duke University School of Medicine selected John Roberts, MD; Jennifer Carbrey, PhD; and Kristen Rhodin, MD, for the annual Golden Apple Awards.

The phase 1 clinical trial, which launched last month, is testing the safety of a vaccine candidate devised under the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program.